Welcome to our dedicated page for EMERGENT HEALTH news (Ticker: EMGE), a resource for investors and traders seeking the latest updates and insights on EMERGENT HEALTH stock.
Emergent Health Corp., now known as Apollo Biowellness, Inc., is a holding company centered on regenerative medicine distributed to medical offices, clinics, and consumers. With subsidiaries like Evolutionary Biologics, Integrative Practice Solutions LLC, and Juventix Regenerative Medical LLC, they are venturing into the $5.6 trillion Global Health & Wellness Market. Their focus includes skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis, and more. With FDA approval pending, the company anticipates growth in skin care and hair products utilizing human exosomes.
Wholistic Brands, a subsidiary of Emergent, epitomizes superior natural formulations from plant-based ingredients, including shelf-stable plant-based exosomes. It aligns with the parent company's objectives and is establishing a direct-to-consumer business around holistic health. The company is under new management, with Jim Morrison as Chairman and President/CEO, bringing his expertise in personal care and biologics to the fore. Morrison's industry experience and leadership are set to steer Emergent Health Corp. into a new era of growth and innovation.
Emergent Health Corp. (OTC PINK:EMGE) announced plans to enhance its financial transparency and visibility by engaging a certified public accountant to audit its financial statements in compliance with SEC GAAP standards. The company intends to file either Form 10 or Form S-1 by Q3 2023 to become a fully reporting SEC entity. Additionally, Emergent plans to up-list to the OTCQB, pending eligibility requirements. CEO Jim Morrison stated that the company has seen consistent revenue growth since August 2022 and is committed to establishing a stronger market presence.
Emergent Health Corp. (EMGE) reported a revenue increase of over 100% for Q4 2022, achieving approximately $408,000 compared to $185,000 in Q3 2022.
The financial statement is set to be filed with OTC Markets by March 31, 2023. The regenerative medicine market is projected to grow from $20.04 billion in 2021 to $125.54 billion by 2030, with a CAGR of 16.2%.
CEO Jim Morrison expressed confidence in the company's ongoing growth and upcoming product launches in 2023.
Emergent Health Corp. (OTC PINK:EMGE) announced that its subsidiary PharmaZu, specializing in pet pharmacy, vet telehealth, and pet wellness, has launched an e-commerce platform targeting the $8.5 billion online pet medicine market. PharmaZu aims to become a leader in this sector by offering convenience, extensive inventory, customer service, and a loyalty program. The pet OTC medication market is projected to grow to $13.2 billion by 2032, with a 4.5% CAGR. CEO Jim Morrison emphasized the company's commitment to creating a comprehensive pet care community.
Emergent Health Corp. (EMGE) has signed a letter of intent to partner with Clicktivated Video, Inc., aiming to integrate shoppable content into its regenerative health product line. This move positions Emergent to leverage Clicktivated’s innovative livestream technology to enhance consumer engagement and drive revenues. The U.S. livestream shopping market is projected to grow from $20 billion this year to $57 billion by 2025, prompting increased demand for interactive shopping experiences.
Emergent Health Corp. (OTC PINK:EMGE) will showcase its regenerative aesthetics products at the 30th Annual A4M Winter World Congress, the leading event in anti-aging and functional medicine, from December 9-11, 2022, in Las Vegas. CEO Jim Morrison expressed optimism about launching innovative products at this event, anticipating a record year for their subsidiary Evolutionary Biologics. A4M has a global membership of over 26,000, promoting advancements in anti-aging medicine, enhancing clinician education for better healthcare outcomes.
Emergent Health Corp. (OTC PINK:EMGE) has executed a letter of intent with Rallis Co. to launch a patented nutrition-based whipped cream. This innovative product line targets both pets and humans, featuring various nutrient profiles. CMO Marvin Segel highlighted the cream's shelf stability and its unique formulation aimed at enhancing pet health. The partnership aims to leverage influencers for marketing, focusing on problem-solution products. The global regenerative medicine market is projected to grow significantly, indicating market potential for Emergent's offerings.
Emergent Health Corp. (OTC PINK:EMGE) announced its new brand, The Wholistic Company, focusing on naturally inspired regenerative health products aimed at supporting human and pet health.
Initial offerings will include healthy bars and shakes, with a marketing strategy emphasizing online and traditional retail sales. The global regenerative medicine market was valued at USD 20.04 billion in 2021 and is projected to reach USD 125.54 billion by 2030, growing at a CAGR of 16.2%.
Emergent Health Corp. (OTC PINK:EMGE) has signed a letter of intent with MeetHook to develop the PharmaZu Virtual Visits platform, offering pet owners 24/7 access to qualified veterinary specialists. This innovative service aims to tap into the USD 119.6 million global veterinary telehealth market, expected to grow at a CAGR of 17.6% until 2030. The platform will feature a revenue-sharing model, allowing professionals to create content for pet owners. Plans to launch the platform are set for early 2023, providing a significant opportunity for revenue generation.
Emergent Health Corp. (OTC PINK:EMGE) has signed a letter of intent to partner with Lumina Industries to kick off a Content Based Marketing Initiative using influencers. The collaboration will see Emergent providing Lumina's 4K webcams to influencers, enhancing consumer engagement through shoppable content. Lumina's AI webcam technology offers features like adaptive color correction and background blurring. This initiative aims to streamline the purchasing process, appealing to the demand for personalized content, as 78% of consumers desire such experiences.
Emergent Health Corp. (OTC PINK:EMGE) announced that Director and Chief Marketing Officer Marvin Segel will appear live today, August 17, 2022, at 2:15 PM ET on the Emerging Growth Conference. Segel, with over 20 years of experience in direct-to-consumer marketing, will discuss his background, the company's status, and key goals for the upcoming year. Emergent specializes in developing products in the Regenerative Health Space, offering both ingestibles and topicals through online distribution and influencer marketing.
FAQ
What is the current stock price of EMERGENT HEALTH (EMGE)?
What is the market cap of EMERGENT HEALTH (EMGE)?
What is Emergent Health Corp. now known as?
What is the main focus of Apollo Biowellness?
What subsidiaries are part of the company?
What markets is Apollo Biowellness targeting?
What is Wholistic Brands?
Who is the new Chairman and President/CEO of Emergent Health Corp.?
What is Jim Morrison's background in the industry?
What growth opportunities does Apollo Biowellness anticipate?
How is Emergent Health Corp. positioned for the future?
What is the distribution strategy of Emergent Health Corp.?
Are Emergent Health Corp. products FDA approved?
